Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells

Sushmita Roy , Keith Spinali , Eric G. Schmuck , John A. Kink , Peiman Hematti , Amish N. Raval
{"title":"Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells","authors":"Sushmita Roy ,&nbsp;Keith Spinali ,&nbsp;Eric G. Schmuck ,&nbsp;John A. Kink ,&nbsp;Peiman Hematti ,&nbsp;Amish N. Raval","doi":"10.1016/j.regen.2020.100033","DOIUrl":null,"url":null,"abstract":"<div><p><span>The polarization of monocytes<span> into macrophages that possess anti-inflammatory and pro-angiogenic properties could provide a novel therapeutic strategy for patients who are at a high risk for developing heart failure following myocardial infarction (MI). Here in, we describe a novel method of “educating” monocytes into a distinct population of macrophages that exhibit anti-inflammatory and pro-angiogenic features through a 3-day culture on fibronectin-rich cardiac matrix (CX) manufactured using cultured human cardiac fibroblasts. Our data suggest that CX can educate monocytes into a unique macrophage population termed CX educated macrophages (CXMq) that secrete high levels of VEGF and IL-6. </span></span><em>In vitro</em><span>, CXMq also demonstrate the ability to recruit mesenchymal stromal cells<span><span> (MSC) with known anti-inflammatory properties. Selective inhibition of fibronectin binding to αVβ3 surface </span>integrins on CXMq prevented MSC recruitment. This suggests that insoluble fibronectin within CX is, at least in part, responsible for CXMq conversion.</span></span></p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"10 ","pages":"Article 100033"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2020.100033","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunology and regenerative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S246849882030007X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

The polarization of monocytes into macrophages that possess anti-inflammatory and pro-angiogenic properties could provide a novel therapeutic strategy for patients who are at a high risk for developing heart failure following myocardial infarction (MI). Here in, we describe a novel method of “educating” monocytes into a distinct population of macrophages that exhibit anti-inflammatory and pro-angiogenic features through a 3-day culture on fibronectin-rich cardiac matrix (CX) manufactured using cultured human cardiac fibroblasts. Our data suggest that CX can educate monocytes into a unique macrophage population termed CX educated macrophages (CXMq) that secrete high levels of VEGF and IL-6. In vitro, CXMq also demonstrate the ability to recruit mesenchymal stromal cells (MSC) with known anti-inflammatory properties. Selective inhibition of fibronectin binding to αVβ3 surface integrins on CXMq prevented MSC recruitment. This suggests that insoluble fibronectin within CX is, at least in part, responsible for CXMq conversion.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心肌成纤维细胞衍生的基质培养巨噬细胞表达VEGF和IL-6,并招募间充质基质细胞
单核细胞分化为巨噬细胞,具有抗炎和促血管生成的特性,可以为心肌梗死(MI)后心力衰竭高风险患者提供一种新的治疗策略。在本文中,我们描述了一种将单核细胞“培养”成巨噬细胞的新方法,通过在富含纤维连接蛋白的心脏基质(CX)上培养3天,这种巨噬细胞表现出抗炎和促血管生成的特征。我们的数据表明,CX可以将单核细胞培养成一种独特的巨噬细胞群,称为CX教育巨噬细胞(CXMq),分泌高水平的VEGF和IL-6。在体外实验中,CXMq还显示出招募具有已知抗炎特性的间充质间质细胞(MSC)的能力。选择性抑制CXMq上纤维连接蛋白与αVβ3表面整合素的结合可阻止MSC的募集。这表明CX中的不溶性纤维连接蛋白至少部分地负责CXMq转换。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom The past, present, and future promise of pluripotent stem cells The past, present, and future promise of pluripotent stem cells Expanding the horizons of cell-based immunotherapies: CAR-neutrophils Xenotransplantation – has its time finally arrived?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1